Good morning from OWITH.ai, the podcast that gives you only what's important to hear in the AI and tech world.In the ever-evolving landscape of healthcare, AI is making significant strides, particularly in transforming doctor visits. In 2025, digital health startups garnered $14.2 billion, with AI-enabled companies capturing a substantial 54% of that investment, according to Rock Health research. Investors are keen on ambient scribes, agentic triage tools, and platforms like Abridge, which secured $550 million in major funding rounds. A survey by Zocdoc revealed that 26% of patients have consulted AI for health queries, with 85% of providers noticing an uptick in AI-informed patients. Despite this trend, over 20% of patients refrain from disclosing their AI use to doctors. However, 77% of healthcare providers view AI positively, preferring it over traditional search engines like Google. Still, this dynamic creates tension as doctors often find themselves correcting AI-generated information. Both parties see AI's role as formulating better questions for doctors. Interestingly, 70% of patients still prefer human medical guidance over AI solutions due to accessibility concerns; average wait times for primary care often exceed 31 days in the U.S.Transitioning to broader tech industry news, significant venture capital activities persist. Normal Computing raised $50 million for AI development led by Samsung Catalyst, and Huskeys secured $8 million for edge security management. Meanwhile, SAP plans to acquire data management software provider Reltio. Several companies have filed for IPOs on Nasdaq: Alamar Biosciences reported $74 million in revenue with backing from Qiming Venture Partners; Kailera Therapeutics is developing GLP-1s for obesity with Bain Capital Life Sciences' support; and Yesway, a convenience store chain with $2.7 billion revenue, is backed by Brookwood Financial Partners.Shifting gears to the tech industry's latest developments as of March 30, 2026, a documentary titled "The AI Doc: Or How I Became an Apocaloptimist" delves into AI advancements' dual nature—highlighting both their potential benefits and societal disruptions. Directed by Daniel Roher, the film presents diverse perspectives on AI through interviews with notable figures like Sam Altman and Demis Hassabis.In financial markets, the "Magnificent Seven" tech stocks including Microsoft and Meta have experienced significant declines attributed to geopolitical tensions and controversies surrounding AI products. Microsoft's shares faced their worst yearly start due to these factors. Elon Musk's ventures also face scrutiny; legal issues involving The Boring Company and XAI highlight operational challenges Musk's companies encounter. Cybersecurity stocks took a hit following a leak about Anthropic's new AI model Claude Mythos, raising concerns about future demand for traditional security solutions.Meanwhile, Amazon acquired Fauna Robotics and Meta announced expansion plans for its Hyperion AI Campus. YouTube CEO Neal Mohan addressed challenges related to free speech while Bluesky launched a new product utilizing Anthropic's technologies. Negotiations between actors' unions and studios over AI-generated characters continue alongside Meta's executive compensation plans tied to ambitious valuation goals.As we segue into geopolitical matters, the ongoing conflict with Iran has reached its fifth week amidst growing frustration among U.S. CEOs toward the Trump administration's policies on tariffs and immigration. The war has led to a significant increase in oil prices with economic impacts costing U.S. taxpayers $1 billion daily and resulting in job losses. At a recent CERAWe

Support the show

Thanks for listening! Follow us on Twitter, Instagram and Linkedin